Testing Ilaprazole for Preventing NSAID-Related Stomach Ulcers
Treatments studied
Part of Digestive system clinical trials.
This study tests a new medicine called Ilaprazole 10 mg to see if it can prevent stomach ulcers caused by NSAIDs (pain relievers like ibuprofen). If you take NSAIDs regularly and have a higher risk of ulcers, this trial may help protect your stomach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years old or older.
- You take NSAID medicines (like ibuprofen or naproxen) regularly or need to start taking them.
- You have at least one risk factor for stomach ulcers, such as a past ulcer or stomach bleeding.
- You do not have serious stomach or esophagus problems, like varices, stricture, or active bleeding.
- You do not have Crohn's disease, colitis, pancreatitis, or a history of cancer in the last 5 years.
- You do not have HIV.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called JP-1366 to see if it can prevent stomach ulcers caused by long-term NSAID use (like ibuprofen or naproxen) for conditions such as arthritis. It may be a good fit if you need to take NSAIDs for at least 24 weeks and have a higher risk of ulcers.
This study tests whether a medication called fexuprazan can protect your stomach from ulcers while you take NSAIDs (common pain relievers like ibuprofen) for ongoing joint or muscle problems. The trial checks if it's safe and works better than standard care.
This trial tests if a new stomach acid medicine (Zastaprazan) affects how well clopidogrel works in heart patients who have had a stent placed. It aims to help people who need both clopidogrel and a stomach acid drug after a procedure.
This phase 1 trial tests a new medicine called IY-828026 in healthy volunteers to see how safe it is and how the body processes it. It's a first step to find the right dose and check for side effects.
This trial tests whether fexuprazan can prevent upper gastrointestinal bleeding in people at high risk who need two antiplatelet drugs for at least 6 months after a heart stent. If you are on dual antiplatelet therapy after a stent and have risk factors like older age, low weight, or history of ulcers, this study may help protect your stomach.
This trial tests a new medicine, zastaprazan, to see if it can prevent stomach or intestinal bleeding in people who have had a stroke or mini-stroke and are taking blood thinners or anti-clotting drugs. It might help protect your stomach while you're on these medications.
Hear when a new Peptic Ulcer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.